Zimmer Biomet share price today

(ZBH)

Zimmer Biomet share price is $106.82 & ₹9,089.85 as on 24 Dec 2024, 2.30 'hrs' IST

$106.82

▲

-0.3

(-0.28%)

Market is closed - opens 8 PM, 24 Dec 2024

View live Zimmer Biomet share price in Dollar and Rupees. Guide to invest in Zimmer Biomet from India. Also see the sentimental analysis on Indian investors investing in Zimmer Biomet. Get details on the Indian mutual funds that are investing in Zimmer Biomet. Get Analyst recommendations and forecasts along with all the Zimmer Biomet's financials.

Zimmer Biomet share price movements

Today's Low: $105.55
Today's High: $106.97
$106.82
1.19%
Downside
Day's Volatility :1.32%
Upside
0.14%
52 Weeks Low: $101.47
52 Weeks High: $133.90
$106.82
5.01%
Downside
52 Weeks Volatility :24.22%
Upside
20.22%

Zimmer Biomet Returns

Period	Zimmer Biomet Holdings, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-0.92%	-10.0%	0.0%
6 Months	-1.29%	-5.7%	0.0%
1 Year	-12.02%	2.8%	0.0%
3 Years	-16.42%	-0.4%	-21.1%

Zimmer Biomet Key Statistics

in dollars & INR

Previous Close	$107.12
Open	$106.31
Today's High	$106.965
Today's Low	$105.55
Market Capitalization	$21.3B
Today's Volume	$1.4M
52 Week High	$133.9
52 Week Low	$101.47
Revenue TTM	$7.6B
EBITDA	$2.6B
Earnings Per Share (EPS)	$5.24
PE Ratio	20.44
Dividend Yield	0.9%
Profit Margin	14.27%
Quarterly Earnings Growth YOY	0.6%
Return On Equity TTM	8.71%

How to invest in Zimmer Biomet from India?

It is very easy for Indian residents to invest directly in Zimmer Biomet from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zimmer Biomet stock in both Indian Rupees (INR) and US Dollars (USD). Search for Zimmer Biomet or ZBH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zimmer Biomet or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zimmer Biomet shares which would translate to 0.008 fractional shares of Zimmer Biomet as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Zimmer Biomet, in just a few clicks!

Returns in Zimmer Biomet for Indian investors in Rupees

Investment Value

₹1,00,000

Zimmer Biomet investment value today

Current value as on today

₹90,298

Returns

₹9,702

(-9.7%)

Returns from Zimmer Biomet Stock

₹12,024 (-12.02%)

Dollar Returns

₹2,322 (+2.32%)

Indian investors sentiment towards Zimmer Biomet

-33%

Period: Sep 24, 2024 to Dec 23, 2024. Change in 30 Days versus previous period

Search volume for Zimmer Biomet on INDmoney from India has reduced in the last 30 days as on Dec 24, 2024. -33% less investors are searching Zimmer Biomet in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Zimmer Biomet

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	1750	-1.17	0.04%
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	84999	2722.52	2.40%

Global Institutional Holdings in Zimmer Biomet

Vanguard Group Inc
11.70%
Dodge & Cox
8.58%
BlackRock Inc
8.46%
T. Rowe Price Associates, Inc.
7.33%
State Street Corp
4.56%
American Century Companies Inc
3.29%

Analyst Recommendation on Zimmer Biomet

Hold

37%Buy

56%Hold

6%Sell

Based on 32 Wall street analysts offering stock ratings for Zimmer Biomet(by analysts ranked 0 to 5 stars)

Based on 32 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Zimmer Biomet

What analysts predicted

Upside of 16.33%

Current:

$106.82

Target:

$124.27

Insights on Zimmer Biomet

Price Movement
In the last 7 days, ZBH stock has moved down by -1.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 1.94B → 1.82B (in $), with an average decrease of 6.1% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 172.4M → 249.2M (in $), with an average increase of 15.8% per quarter
ZBH vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 60.8% return, outperforming this stock by 72.2%
ZBH vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 110.3% return, outperforming this stock by 126.2%
Price to Sales
ForZBH every $1 of sales, investors are willing to pay $2.9, whereas for Boston Scientific Corp., the investors are paying $8.3 for every $1 of sales.

Zimmer Biomet Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$7.9B	↑ 1.39%
Net Income	$-379.2M	↓ 120.61%
Net Profit Margin	-4.78%	↓ 28.29%

	FY19	Y/Y Change
Revenue	$8.0B	↑ 0.62%
Net Income	$1.1B	↓ 398.42%
Net Profit Margin	14.18%	↑ 18.96%

	FY20	Y/Y Change
Revenue	$7.0B	↓ 12.0%
Net Income	$-137.4M	↓ 112.14%
Net Profit Margin	-1.96%	↓ 16.14%

	FY21	Y/Y Change
Revenue	$6.8B	↓ 2.81%
Net Income	$401.6M	↓ 392.29%
Net Profit Margin	5.88%	↑ 7.84%

	FY22	Y/Y Change
Revenue	$6.9B	↑ 1.65%
Net Income	$231.4M	↓ 42.38%
Net Profit Margin	3.33%	↓ 2.55%

	FY23	Y/Y Change
Revenue	$7.4B	↑ 6.55%
Net Income	$1.0B	↑ 342.52%
Net Profit Margin	13.85%	↑ 10.52%

	Q2 FY23	Q/Q Change
Revenue	$1.9B	↑ 2.11%
Net Income	$209.6M	↓ 9.85%
Net Profit Margin	11.21%	↓ 1.49%

	Q3 FY23	Q/Q Change
Revenue	$1.8B	↓ 6.2%
Net Income	$162.7M	↓ 22.38%
Net Profit Margin	9.28%	↓ 1.93%

	Q4 FY23	Q/Q Change
Revenue	$1.9B	↑ 10.64%
Net Income	$419.2M	↑ 157.65%
Net Profit Margin	21.61%	↑ 12.33%

	Q1 FY24	Q/Q Change
Revenue	$1.9B	↓ 2.62%
Net Income	$172.4M	↓ 58.87%
Net Profit Margin	9.13%	↓ 12.48%

	Q2 FY24	Q/Q Change
Revenue	$1.9B	↑ 2.79%
Net Income	$242.8M	↑ 40.84%
Net Profit Margin	12.5%	↑ 3.37%

	Q3 FY24	Q/Q Change
Revenue	$1.8B	↓ 6.07%
Net Income	$249.2M	↑ 2.64%
Net Profit Margin	13.66%	↑ 1.16%

	FY18	Y/Y Change
Profit	$5.7B	↓ 0.53%

	FY19	Y/Y Change
Profit	$5.7B	↑ 1.21%

	FY20	Y/Y Change
Profit	$4.9B	↓ 14.55%

	FY21	Y/Y Change
Profit	$4.9B	↓ 0.6%

	FY22	Y/Y Change
Profit	$4.9B	↑ 1.1%

	FY23	Y/Y Change
Profit	$5.3B	↑ 7.93%

	Q2 FY23	Q/Q Change
Profit	$1.3B	↑ 1.04%

	Q3 FY23	Q/Q Change
Profit	$1.2B	↓ 8.12%

	Q4 FY23	Q/Q Change
Profit	$1.4B	↑ 13.47%

	Q1 FY24	Q/Q Change
Profit	$1.2B	↓ 16.55%

	Q2 FY24	Q/Q Change
Profit	$1.2B	↑ 0.79%

	Q3 FY24	Q/Q Change
Profit	$1.3B	↑ 9.08%

	FY18	Y/Y Change
Operating Cash Flow	$1.7B	↑ 10.43%
Investing Cash Flow	$-416.6M	↓ 18.44%
Financing Cash Flow	$-1.3B	↑ 7.58%

	FY19	Y/Y Change
Operating Cash Flow	$1.6B	↓ 9.25%
Investing Cash Flow	$-729.3M	↑ 75.06%
Financing Cash Flow	$-779.9M	↓ 40.11%

	FY20	Y/Y Change
Operating Cash Flow	$1.2B	↓ 24.04%
Investing Cash Flow	$-613.8M	↓ 15.84%
Financing Cash Flow	$-421.8M	↓ 45.92%

	FY21	Y/Y Change
Operating Cash Flow	$1.5B	↑ 24.47%
Investing Cash Flow	$-503.6M	↓ 17.95%
Financing Cash Flow	$-1.3B	↑ 209.63%

	FY22	Y/Y Change
Operating Cash Flow	$1.3B	↓ 14.31%
Investing Cash Flow	$-529.2M	↑ 5.08%
Financing Cash Flow	$-843.8M	↓ 35.39%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$347.9M	↑ 13.06%
Investing Cash Flow	$-392.5M	↑ 162.72%
Financing Cash Flow	$-109.4M	↓ 47.07%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$337.6M	↓ 2.96%
Investing Cash Flow	$-558.1M	↑ 42.19%
Financing Cash Flow	$-196.0M	↑ 79.16%

Zimmer Biomet Technicals Summary

Sell

Neutral

Buy

Zimmer Biomet is currently in a neutral trading position according to technical analysis indicators.

Zimmer Biomet Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zimmer Biomet Holdings, Inc.	-3.73%	-1.29%	-12.02%	-16.42%	-28.93%
Stryker Corporation	-4.79%	7.93%	22.54%	35.53%	74.73%
Boston Scientific Corp.	0.68%	15.93%	60.49%	108.4%	98.54%
Edwards Lifesciences Corp.	4.97%	-17.86%	-1.93%	-42.71%	-4.81%
Abbott Laboratories	-3.23%	8.36%	4.65%	-19.19%	30.97%
Medtronic Plc	-5.07%	1.23%	-1.09%	-22.05%	-27.7%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zimmer Biomet Holdings, Inc.	20.44	20.44	1.4	7.98	0.09	0.05	0.01	62.0
Stryker Corporation	39.08	39.08	2.55	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.51	73.51	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.87	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.72	34.72	2.21	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.78	24.78	1.48	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zimmer Biomet Holdings, Inc.	Hold	$21.3B	-28.93%	20.44	14.27%
Stryker Corporation	Buy	$139.0B	74.73%	39.08	16.34%
Boston Scientific Corp.	Buy	$131.1B	98.54%	73.51	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-4.81%	28.88	65.86%
Abbott Laboratories	Buy	$198.1B	30.97%	34.72	13.99%
Medtronic Plc	Buy	$103.9B	-27.7%	24.78	12.06%

Zimmer Biomet Dividend announcements

Zimmer Biomet Dividends December, 2024
In the quarter ending December,2024. Zimmer Biomet has declared dividend of $0.24
Read More

About Zimmer Biomet

zimmer biomet is the world’s most trusted brand for personalized bone and joint healthcare solutions. we help people discover and achieve exceptional outcomes. as a leading innovator in musculoskeletal healthcare, we offer a complete portfolio of products for joint reconstruction, bone and skeletal repair, sports medicine, spine, and dental reconstruction. every day, we focus on improving musculoskeletal healthcare. it’s all we do. it’s all we’ve ever done. for nearly 90 years, zimmer biomet has helped people progress beyond their pain and limitations. because it’s not just what we make, it’s what we make possible. zimmer biomet serves healthcare professionals and their patients globally. our worldwide headquarters is in warsaw, indiana, usa.

Organization	Zimmer Biomet
Employees	18000
CEO	Mr. Ivan Tornos
Industry	Health Technology

Management People of Zimmer Biomet

Name	Title
Mr. Ivan Tornos	COO, President, CEO & Director
Mr. Suketu P. Upadhyay	CFO and Executive VP of Finance, Operations & Supply Chain
Mr. Chad F. Phipps J.D.	Senior VP, General Counsel & Secretary
Mr. Sang Yi	President of Asia Pacific
Mr. Wilfred van Zuilen	Group President of Europe, Middle East & Africa
Mr. Paul A. Stellato	VP, Controller & Chief Accounting Officer
Mr. Shaun Braun	Senior VP & Chief Information and Technology Officer
Ms. Rachel H. Ellingson	Senior VP & Chief Administrative Officer
Mr. David M. DeMartino	Senior VP of Investor Relations
Ms. Angela Main	Senior VP, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific

Important FAQs about investing in Zimmer Biomet from India :

What is Zimmer Biomet share price today?

Zimmer Biomet share price today stands at $106.82, Open: $106.31 ; Previous Close: $107.12 ; High: $106.97 ; Low: $105.55 ; 52 Week High: $133.90 ; 52 Week Low: $101.47. The stock opens at $106.31, after a previous close of $107.12. The stock reached a daily high of $106.97 and a low of $105.55, with a 52-week high of $133.90 and a 52-week low of $101.47.

Can Indians buy Zimmer Biomet shares?

Yes, Indians can invest in the Zimmer Biomet (ZBH) from India.

With INDmoney, you can buy Zimmer Biomet at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Zimmer Biomet at zero transaction cost.

How can I buy Zimmer Biomet shares from India?

It is very easy to buy Zimmer Biomet from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zimmer Biomet be purchased?

Yes, you can buy fractional shares of Zimmer Biomet with INDmoney app.

What are the documents required to start investing in Zimmer Biomet stocks?

To start investing in Zimmer Biomet, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.